Related Experiment Video
Updated: Apr 17, 2026

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
Long noncoding RNAs and microRNAs in cardiovascular pathophysiology
Thomas Thum1, Gianluigi Condorelli2
1From the Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Integrated Research and Treatment Center Transplantation, and REBIRTH Excellence Cluster, Hannover Medical School, Hannover, Germany (T.T.); National Heart and Lung Institute, Imperial College London, London, United Kingdom (T.T.); Humanitas Clinical and Research Center, Rozzano, Milan, Italy (G.C.); Institute of Genetics and Biomedical Research, National Research Country of Italy, Milan, Italy (G.C.); University of Milan, Milan, Italy (G.C.); and Department of Cardiovascular Sciences, University of Leicester, Leicester, United Kingdom (G.C.). thum.thomas@mh-hannover.de gianluigi.condorelli@humanitasresearch.it.
Non-coding RNAs regulate cellular functions and their malfunction is linked to disease. This review focuses on long noncoding RNAs and microRNAs in cardiac hypertrophy and heart failure.
Area of Science:
- Molecular Biology
- Cardiovascular Biology
- Genetics
Background:
- Non-coding RNAs (ncRNAs) are crucial regulators of cellular processes.
- Dysregulation of ncRNAs is implicated in various pathologies.
- The cardiovascular system is increasingly recognized as being affected by ncRNA dysfunction.
Purpose of the Study:
- To review recent findings on the pathophysiological roles of ncRNAs in the cardiovascular system.
- To highlight the specific involvement of long noncoding RNAs (lncRNAs) and microRNAs (miRNAs) in cardiac hypertrophy and heart failure.
Main Methods:
- Literature review of recent scientific reports.
- Focus on studies investigating lncRNAs and miRNAs.
- Analysis of their roles in cardiac hypertrophy and heart failure models.
Main Results:
- Recent research highlights the significant role of ncRNAs in cardiovascular diseases.
- lncRNAs and miRNAs are key players in the development and progression of cardiac hypertrophy.
- These non-coding RNAs are also implicated in the pathophysiology of heart failure.
Conclusions:
- ncRNAs, particularly lncRNAs and miRNAs, are critical regulators in cardiovascular health and disease.
- Understanding their roles in cardiac hypertrophy and failure offers potential therapeutic targets.
- Further investigation into ncRNA mechanisms is warranted for cardiovascular disease treatment.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
MicroRNAs
MicroRNAs
MicroRNAs
Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...

